metabolic syndrome. mellitusHypertensive heart disease Disorders of lipoprotein metabolism and other lipidaemias, Obesity, Other specified diabetes
Conditions
Interventions
Intervention 1: In the GFD group, patients were assumed to receive less than 2-gram gluten per day for eight weeks. Through the intervention process,individuals received gluten free breads. Additional
In the GFD group, patients were assumed to receive less than 2-gram gluten per day for eight weeks. Through the intervention process,individuals received gluten free breads. Additionally, participants
control group, were informed to continue their regular diet for eight weeks. . A recommendation sheet containing information regarding controlling overweight and obesity was provided to participants
Sponsors
National Nutrition and Food Sciences Technology Research Institute
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: having at least three of the dimensions of metabolic syndrome, including weight circumference=95cm for both genders, high blood pressure (systolic blood pressure=130mmHg and diastolic blood pressure=85mmHg) and high triglyceride (>150 mg/dL) Age range 25-65 years BMI =25kg/m2
Exclusion criteria
Exclusion criteria: using fat burning and weight loss drugs, multivitamin/mineral, omega-3 and green tea supplements in the past month using insulin or drugs (Metformin or Glibenclamide) for controlling blood sugar having thyroid gland disorders Pregnancy and Lactation ,athletics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting glucose. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: enzymatic method.;Triglycerid. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: enzymatic method.;Body weight. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: scale.;Waist circumstance. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: meter.;Systolic and diastolic pressure. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: barometer.;Hs-CRP. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: ELISA.;HDL. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: enzymatic method.;Cholestrol. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: enzymatic method.;TNF-. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: ELISA.;Serum insulin. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: ELISA.;Intestinal microflora. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: Real-time PCR. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dietary intake of macronutrient. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: food recall questionnaire.;Dietary intake of energy. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: food recall questionnaire.;LDL. Timepoint: beginning of trial/ end of trial (2 months later). Method of measurement: Friedwald. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzita Hekmatdoost
Faculty of Nutrition and Food Sciences
Outcome results
None listed